Life Isn’t Structured. Data Shouldn’t Have To Be.

Football legend Terry Bradshaw recently revealed he beat cancer twice. The former Pittsburgh Steelers quarterback said he had bladder and a rare, aggressive type of skin cancer called a Merkel cell tumor in the same year. While Bradshaw is open about his health issues now, he never planned on sharing the news.

According to the American Cancer Society, the risk of dying from cancer has decreased over the last 28 years. "The cancer death rate for men and women combined fell 32% from its peak in 1991 to 2019, the most recent year for which data were available."

Learning you have an incurable cancer is not a diagnosis anyone is ever prepared for. While cancer can cause almost every symptom imaginable, oftentimes there's no warning signs until the cancer has spread making it difficult to treat.

New partnership brings accurate trial recommendations to Azra AI’s national client base of medical systems and hospitals, including leading healthcare providers.

Cancer death rates in the United States have been experiencing a steady decline, dropping 2.3% per year every year from 2016 through 2019, according to a new report from the American Association for Cancer Research (AACR).

Now in use in more than 200 medical systems and hospitals across the country, Azra AI's technology helps clinicians and medical teams identify suspicious findings that could lead to an earlier cancer diagnosis for patients, where treatment options allow patients to potentially be cured. These findings are detected in patients that receive imaging primarily for other healthcare illnesses or conditions, which explains the term "incidental." Azra AI's technology identifies cancers that often have no symptoms until the cancer is late stage. 

Seasoned healthcare executive Brook Blackmore has joined the leadership team of Azra AI, a company whose technology identifies positive cancer diagnoses and incidental findings in real-time with an eye toward helping patients and clinicians. 

For most people, the shock of a cancer diagnosis quickly gives way to an action plan — disease research, doctor appointments, treatment options, and support outlets. But many patients are not able to take these steps or advocate for themselves. Some simply don't know how to move forward, which results in more complicated and expensive care, reduced life expectancies, and inferior health outcomes.

The CEO said the acquisition from Smarsh, which closed in January on undisclosed terms, was made by Azra's owner, Invenero Health LLC. Invenero was registered in Delaware the same day as Invenero Holdings Inc., VNC research shows.

Azra AI is touting a milestone in the use of its artificial intelligence (AI) technology for identifying cancer diagnoses in real-time and in turn, improving patient care.

For cancer patients and their loved ones, days, weeks, and months matter. In fact, anyone who has waited anxiously for test results or a treatment regimen to begin can attest that hours, or even minutes, will drag on with emotional heaviness.